Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: Intratumoral molecular heterogeneity

Medicine and Dentistry

• Malignant Neoplasm 100%
• Gene Mutation 100%
• Somatics 100%
• Ovarian Tumor 100%
• Heterozygosity 100%
• Neoplasm 33%
• Carcinogenesis 33%
• Metastatic Carcinoma 33%
• Precursor 33%
• Tumor Suppressor Gene 33%
• Ovarian Cancer 33%
• Primary Tumor 33%
• Lip 33%
• Benign Tumor 33%

Biochemistry, Genetics and Molecular Biology

• Gene Mutation 100%
• Loss of Heterozygosity 100%
• Chromosome Regions 66%
• Precursor 33%
• Genetics 33%
• Carcinogenesis 33%
• Tumor Suppressor Gene 33%

Keyphrases

• Molecular Heterogeneity 100%
• Malignant Ovarian Tumor 33%
• Benign Ovarian Tumor 33%
• Borderline Ovarian Tumor 33%
• Precursor Lesions 33%
• Advanced Malignant Tumor 33%